Error: Could not add to watchlist. X
+ Watchlist

Bradmer Pharmaceuticals Inc

BMR/H:CN
Venture
0.01
CAD
0.00
0.00%
As of 2:39 PM EDT 7/7/2016
Volume
13,500
Previous Close
0.01
52Wk Range
0.01 - 0.02
Volume
13,500
Previous Close
0.01
52Wk Range
0.01 - 0.02
YTD Return
-50.00%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.01
Market Cap (k CAD)
196.597
Shares Outstanding (m)
19.660
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Bradmer Pharmaceuticals Inc. is a biotechnology company focused on development and commercialization of cancer therapies. The lead product candidate, Neuradiab, is a therapy against certain brain cancers.
Address
Wildeboer Dellelce Place
365 Bay Street Suite 800
Toronto, ON M5H 2V1
Canada
Phone
1-416-361-6058
  • Alan Mark Ezrin
    Chairman/President/CEO
  • Paul J Van Damme
    Chief Financial Officer
Show More